<?xml version="1.0" encoding="UTF-8"?>
<p id="para0009">Oseltamivir is orally bioavailable and well-tolerated. Reflecting this excellent safety profile, the drug has been approved for use also in pregnant women, pediatric patients, and neonates.
 <xref rid="bib0029" ref-type="bibr">
  <sup>29</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib0032" ref-type="bibr">
  <sup>32</sup>
 </xref> As discussed above, clinical trials have shown that NAIs provide benefit when started early after infection.
 <xref rid="bib0009" ref-type="bibr">
  <sup>9</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib0033" ref-type="bibr">
  <sup>33</sup>
 </xref> However, meta-analyses of clinical data revealed little effect on reducing influenza-associated complications or hospitalization,
 <xref rid="bib0034" ref-type="bibr">34</xref>, 
 <xref rid="bib0035" ref-type="bibr">35</xref>, 
 <xref rid="bib0036" ref-type="bibr">36</xref>, 
 <xref rid="bib0037" ref-type="bibr">37</xref> and some data suggested that late treatment with NAIs could have enhanced the risk of progression to severe disease in the 2009/2010 pandemic.
 <xref rid="bib0038" ref-type="bibr">
  <sup>38</sup>
 </xref>
</p>
